Wilmington Savings Fund Society’s Recursion Pharmaceuticals RXRX Stock Holding History

Wilmington Savings Fund Society’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.83K	Hold	772	–	–	﹤0.01%	1321
2026 Q1	$2.37K	Hold	772	–	–	﹤0.01%	1337
2025 Q4	$3.16K	Hold	772	–	–	﹤0.01%	1282
2025 Q3	$3.77K	Hold	772	–	–	﹤0.01%	1257
2025 Q2	$3.91K	Hold	772	–	–	﹤0.01%	1797
2025 Q1	$4.08K	Hold	772	–	–	﹤0.01%	1813
2024 Q4	$5.22K	Buy	+772	New	+$5.19K	﹤0.01%	1799

Other funds holding RXRX

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Carroll Investors Mt Pleasant, South Carolina $234M AUM 59.79% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Wilmington Savings Fund Society's RXRX Position: Q2 2026 in Review

Wilmington Savings Fund Society held its Recursion Pharmaceuticals (RXRX) position steady in Q2 2026 at 772 shares worth $2.83K. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

Wilmington Savings Fund Society first reported a position in RXRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.22K in Q4 2024. 107 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

Wilmington Savings Fund Society held 772 shares of Recursion Pharmaceuticals worth $2.83K as of Q2 2026.
Wilmington Savings Fund Society left its Recursion Pharmaceuticals share count unchanged in Q2 2026.
Recursion Pharmaceuticals made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #1321 holding.
Wilmington Savings Fund Society first reported a position in Recursion Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Wilmington Savings Fund Society's Recursion Pharmaceuticals position peaked at $5.22K in Q4 2024.
107 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.